Market Cap 24.30M
Revenue (ttm) 0.00
Net Income (ttm) -33.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 338,500
Avg Vol 1,602,010
Day's Range N/A - N/A
Shares Out 61.97M
Stochastic %K 29%
Beta 1.01
Analysts Strong Sell
Price Target $5.40

Latest News on CGTX

Cognition Therapeutics CEO Issues Letter to Shareholders

Jan 4, 2024, 7:30 AM EST - 1 year ago

Cognition Therapeutics CEO Issues Letter to Shareholders